TRVI vs. DBVT

Last updated Aug 1, 2026

TRVI (Trevi Therapeutics, Inc.) and DBVT (DBV Technologies S.A.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, TRVI returned 57.22%/yr vs -23.64%/yr for DBVT. Their 0.12 correlation means their historical movements had little consistent relationship.

Performance

TRVI vs. DBVT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Trevi Therapeutics, Inc. (TRVI) and DBV Technologies S.A. (DBVT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TRVI achieves a 45.77% return, which is significantly higher than DBVT's -29.58% return.

TRVI

• 1D: -0.82%
• 1M: 1.78%
• 6M: 74.31%
• YTD: 45.77%
• 1Y: 148.98%
• 3Y*: 94.77%
• 5Y*: 57.22%
• 10Y*: —
• ALL TIME*: 9.45%

DBVT

• 1D: -2.24%
• 1M: -14.66%
• 6M: -37.53%
• YTD: -29.58%
• 1Y: 50.00%
• 3Y*: -5.70%
• 5Y*: -23.64%
• 10Y*: -27.66%
• ALL TIME*: -21.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
DBVT DBV Technologies S.A.	$4.97M	$4.31M	$4.66M
TRVI Trevi Therapeutics, Inc.	$32.53M	$46.29M	$34.89M

TRVI vs. DBVT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
TRVI Trevi Therapeutics, Inc.	45.77%	203.88%	207.46%	-30.57%	146.74%	-67.68%	-35.47%	-60.53%
DBVT DBV Technologies S.A.	-29.58%	520.39%	-67.57%	-37.73%	-4.37%	-38.93%	-75.51%	10.08%

Correlation

The correlation between TRVI and DBVT is 0.18, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.18
Correlation (3Y) Balances recent behavior with more history.	0.08
Correlation (5Y) Shows whether the relationship held over a longer period.	0.10
Correlation (All Time) Calculated using the full available price history since May 7, 2019	0.12

Fundamentals

Market Cap TRVI : $2.59B DBVT : $322.94M
EPS TRVI : -$0.47 DBVT : -$0.00
Total Revenue (TTM) TRVI : $0.00 DBVT : $0.00
Gross Profit (TTM) TRVI : -$31.00K DBVT : -$12.78M
EBITDA (TTM) TRVI : -$49.16M DBVT : -$162.79M

Return for Risk

TRVI vs. DBVT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TRVI

TRVI Risk / Return Rank: 92
TRVI Sharpe Ratio Rank: 94
TRVI Sortino Ratio Rank: 90
TRVI Omega Ratio Rank: 90
TRVI Calmar Ratio Rank: 95
TRVI Martin Ratio Rank: 93

DBVT

DBVT Risk / Return Rank: 72
DBVT Sharpe Ratio Rank: 70
DBVT Sortino Ratio Rank: 76
DBVT Omega Ratio Rank: 70
DBVT Calmar Ratio Rank: 71
DBVT Martin Ratio Rank: 71

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TRVI vs. DBVT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Trevi Therapeutics, Inc. (TRVI) and DBV Technologies S.A. (DBVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TRVI	DBVT	Difference
Sharpe ratio: Return per unit of total volatility	2.32	0.78	+1.54
Sortino ratio: Return per unit of downside risk	2.73	1.79	+0.94
Omega ratio: Gain probability vs. loss probability	1.36	1.20	+0.16
Calmar ratio: Return relative to maximum drawdown	4.99	1.31	+3.68
Martin ratio: Return relative to average drawdown	11.73	2.97	+8.76

TRVI vs. DBVT - Sharpe Ratio Comparison

The current TRVI Sharpe Ratio is 2.32, which is higher than the DBVT Sharpe Ratio of 0.78. The chart below compares the historical Sharpe Ratios of TRVI and DBVT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TRVI vs. DBVT - Drawdown Comparison

The maximum TRVI drawdown since its inception was -95.45%, roughly equal to the maximum DBVT drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for TRVI and DBVT.

Drawdown Indicators

	TRVI	DBVT	Difference
Max Drawdown Largest peak-to-trough decline	-95.45%	-99.52%	+4.07%
Max Drawdown (1Y) Largest decline over 1 year	-29.50%	-44.99%	+15.49%
Max Drawdown (3Y) Largest decline over 3 years	-55.99%	-86.60%	+30.61%
Max Drawdown (5Y) Largest decline over 5 years	-78.10%	-96.04%	+17.94%
Max Drawdown (10Y) Largest decline over 10 years	—	-99.52%	—
Current Drawdown Current decline from peak	-6.41%	-97.26%	+90.85%
Average Drawdown Average peak-to-trough decline	-60.47%	-70.60%	+10.13%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.53%	19.82%	-7.29%

Volatility

TRVI vs. DBVT - Volatility Comparison

Trevi Therapeutics, Inc. (TRVI) has a higher volatility of 25.44% compared to DBV Technologies S.A. (DBVT) at 15.64%. This indicates that TRVI's price experiences larger fluctuations and is considered to be riskier than DBVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TRVI	DBVT	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.44%	15.64%	+9.80%
Volatility (6M) Calculated over the trailing 6-month period	42.50%	40.42%	+2.08%
Volatility (1Y) Calculated over the trailing 1-year period	63.41%	75.79%	-12.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	88.77%	92.74%	-3.97%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	98.98%	85.63%	+13.35%

Dividends

TRVI vs. DBVT - Dividend Comparison

Neither TRVI nor DBVT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both TRVI and DBVT in my portfolio?

TRVI and DBVT have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TRVI or DBVT?

TRVI has higher volatility (25.44%) compared to DBVT (15.64%). In terms of maximum drawdown, TRVI dropped -95.45% vs DBVT's -99.52%.

Which has better risk-adjusted returns?

TRVI currently has the higher Sharpe Ratio (2.32 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.